Lipsky, Andrew
111  results:
Search for persons X
?
5

CLL-542 High Rates of Undetectable Minimal Residual Disease..:

Lipsky, Andrew ; Hill, Brian ; Winter, Allison...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S328 , 2023
 
?
6

POSTER: ABCL-600 Diagnostic Utility of the 18F-FDG PET/CT S..:

Cherng, Hua-Jay ; Capaccione, Kathleen ; Ma, Hong...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S203 , 2023
 
?
7

ABCL-600 Diagnostic Utility of the 18F-FDG PET/CT Scan in E..:

Cherng, Hua-Jay ; Capaccione, Kathleen ; Ma, Hong...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S442 , 2023
 
?
8

EXABS-209-CLL The Case for Extending Treatment in MRD+ Pati..:

Lipsky, Andrew ; Lamanna, Nicole
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S98-S99 , 2023
 
?
9

Measurable Residual Disease Monitoring in Lymphoma:

Cuzzo, Brian ; Lipsky, Andrew ; Cherng, Hua-Jay J.
Current Hematologic Malignancy Reports.  18 (2023)  6 - p. 292-304 , 2023
 
?
10

POSTER: CLL-542 High Rates of Undetectable Minimal Residual..:

Lipsky, Andrew ; Hill, Brian ; Winter, Allison...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S173 , 2023
 
?
12

Poster: ABCL-542 Prevalence and Characterization of EBV-Neg..:

Ford, Maegan ; Jin, Zhezhen ; Orlando, Evelyn...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S170 , 2022
 
?
13

ABCL-542 Prevalence and Characterization of EBV-Negative Po..:

Ford, Maegan ; Jin, Zhezhen ; Orlando, Evelyn...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S382-S383 , 2022
 
1-15